Pfizer Options Trading: A Deep Dive into Market Sentiment
Portfolio Pulse from Benzinga Insights
Deep-pocketed investors have shown a bearish sentiment towards Pfizer (NYSE:PFE), as revealed by Benzinga's options scanner. The scanner detected 11 unusual options activities, with a mix of bullish and bearish sentiments, but a slight majority leaning bearish. The significant trading activity suggests a price target range of $20.0 to $32.5 for Pfizer in the next three months. Analysts have recently adjusted their ratings and price targets for Pfizer, with an average price target of $42.0. The company's current market performance shows a slight increase in stock price, with an upcoming earnings announcement in 40 days.
March 21, 2024 | 3:31 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Pfizer has seen a bearish sentiment from deep-pocketed investors according to Benzinga's options scanner, with a predicted price range of $20.0 to $32.5 in the short term. Analysts have recently adjusted their ratings and price targets, setting an average price target of $42.0. The company's stock price has seen a slight increase, with an upcoming earnings announcement in 40 days.
The bearish sentiment among investors, as indicated by options trading activity, could lead to increased volatility in Pfizer's stock price in the short term. However, the presence of bullish options and recent analyst adjustments to price targets and ratings suggest a mixed outlook. The upcoming earnings announcement will be crucial in determining the stock's direction, making the short-term impact neutral as the market awaits further clarity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100